74 related articles for article (PubMed ID: 9536082)
1. Functional analysis of the Huntington's disease (HD) gene promoter.
Coles R; Caswell R; Rubinsztein DC
Hum Mol Genet; 1998 May; 7(5):791-800. PubMed ID: 9536082
[TBL] [Abstract][Full Text] [Related]
2. 12-O-tetradecanoyl-phorbol-13-acetate down-regulates the Huntingtin promoter at Sp1 sites.
Coles R; Birdsall M; Wyttenbach A; Rubinsztein DC
Neuroreport; 2000 Sep; 11(14):3157-61. PubMed ID: 11043541
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the human Huntington's disease gene promoter.
Holzmann C; Schmidt T; Thiel G; Epplen JT; Riess O
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):85-97. PubMed ID: 11483245
[TBL] [Abstract][Full Text] [Related]
4. Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease.
Chen-Plotkin AS; Sadri-Vakili G; Yohrling GJ; Braveman MW; Benn CL; Glajch KE; DiRocco DP; Farrell LA; Krainc D; Gines S; MacDonald ME; Cha JH
Neurobiol Dis; 2006 May; 22(2):233-41. PubMed ID: 16442295
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of the rat huntingtin promoter.
Holzmann C; Mäueler W; Petersohn D; Schmidt T; Thiel G; Epplen JT; Riess O
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):227-34. PubMed ID: 9806905
[TBL] [Abstract][Full Text] [Related]
6. Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington's disease gene.
Tanaka K; Shouguchi-Miyata J; Miyamoto N; Ikeda JE
J Biol Chem; 2004 Feb; 279(8):7275-86. PubMed ID: 14625278
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of REST by Sp1 in Huntington's disease models.
Ravache M; Weber C; Mérienne K; Trottier Y
PLoS One; 2010 Dec; 5(12):e14311. PubMed ID: 21179468
[TBL] [Abstract][Full Text] [Related]
8. Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A.
Hu H; McCaw EA; Hebb AL; Gomez GT; Denovan-Wright EM
Eur J Neurosci; 2004 Dec; 20(12):3351-63. PubMed ID: 15610167
[TBL] [Abstract][Full Text] [Related]
9. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
[TBL] [Abstract][Full Text] [Related]
10. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells.
Chiang MC; Cheng YC; Nicol CJ; Lin KH; Yen CH; Chen SJ; Huang RN
Exp Cell Res; 2015 Nov; 338(2):183-93. PubMed ID: 26362846
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
[TBL] [Abstract][Full Text] [Related]
13. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.
Benn CL; Sun T; Sadri-Vakili G; McFarland KN; DiRocco DP; Yohrling GJ; Clark TW; Bouzou B; Cha JH
J Neurosci; 2008 Oct; 28(42):10720-33. PubMed ID: 18923047
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the miniature pig Huntington's disease gene homolog: evidence for conservation and polymorphism in the CAG triplet repeat.
Matsuyama N; Hadano S; Onoe K; Osuga H; Showguchi-Miyata J; Gondo Y; Ikeda JE
Genomics; 2000 Oct; 69(1):72-85. PubMed ID: 11013077
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Cui L; Jeong H; Borovecki F; Parkhurst CN; Tanese N; Krainc D
Cell; 2006 Oct; 127(1):59-69. PubMed ID: 17018277
[TBL] [Abstract][Full Text] [Related]
16. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR
Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
18. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
[TBL] [Abstract][Full Text] [Related]
19. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease.
Zuleta A; Vidal RL; Armentano D; Parsons G; Hetz C
Biochem Biophys Res Commun; 2012 Apr; 420(3):558-63. PubMed ID: 22445760
[TBL] [Abstract][Full Text] [Related]
20. Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice.
McCaw EA; Hu H; Gomez GT; Hebb AL; Kelly ME; Denovan-Wright EM
Eur J Biochem; 2004 Dec; 271(23-24):4909-20. PubMed ID: 15606779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
